NUCLEAR MEDICINE BOARD EXAM 2 LATEST
VERSIONS AND STUDY GUIDE (VERSION A AND
B) 2025-2026 ACTUAL EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS
In imaging with 67Gacitrate, remaining the same while blood clearance progresses
target-tobackground ratio
increases over time because
of gallium concentration in
tissue: remaining the same
while blood clearance
progresses decreasing while
blood clearance progresses
remaining the same while
blood clearance decreases
decreasing while blood
clearance decreases
at six hours
Following the injection of
67Ga-citrate, imaging can
begin:
immediately at
one hour at
three hours at
six hours
,A technologist is positioning change the collimator to a high-energy collimator
a patient for a 67Ga-citrate
imaging study and notices
that a LEAP collimator is on
the camera. The
recommended action for the
technologist to take is to:
continue positioning the
patient; the correct
collimator is in place.
change the collimator to a
GAP collimator change the
collimator to a medium-
energy collimator change the
collimator to a high-energy
collimator
, continue imaging because this is normal
A 67Ga image at 48 hours
after injection displays bowel
activity; the technologist
should: be concerned that
the wrong
radiopharmaceutical was
administered change the
collimator to reduce the
scatter activity from the
bowel continue imaging
because this is normal check
to see if a radiographic study
using contrast was
performed
When imaging abscesses it 111In-oxine-labeled WBC is superior to 111In chloride
has been demonstrated
that:
67Ga-citrate is superior to
111In-oxine-labeled WBC
111In-oxine-labeled WBC is
superior to 111In chloride
111In chloride is superior to
111In-oxine-labeled WBC
111In chloride is superior to
67Ga-citrate
VERSIONS AND STUDY GUIDE (VERSION A AND
B) 2025-2026 ACTUAL EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS
In imaging with 67Gacitrate, remaining the same while blood clearance progresses
target-tobackground ratio
increases over time because
of gallium concentration in
tissue: remaining the same
while blood clearance
progresses decreasing while
blood clearance progresses
remaining the same while
blood clearance decreases
decreasing while blood
clearance decreases
at six hours
Following the injection of
67Ga-citrate, imaging can
begin:
immediately at
one hour at
three hours at
six hours
,A technologist is positioning change the collimator to a high-energy collimator
a patient for a 67Ga-citrate
imaging study and notices
that a LEAP collimator is on
the camera. The
recommended action for the
technologist to take is to:
continue positioning the
patient; the correct
collimator is in place.
change the collimator to a
GAP collimator change the
collimator to a medium-
energy collimator change the
collimator to a high-energy
collimator
, continue imaging because this is normal
A 67Ga image at 48 hours
after injection displays bowel
activity; the technologist
should: be concerned that
the wrong
radiopharmaceutical was
administered change the
collimator to reduce the
scatter activity from the
bowel continue imaging
because this is normal check
to see if a radiographic study
using contrast was
performed
When imaging abscesses it 111In-oxine-labeled WBC is superior to 111In chloride
has been demonstrated
that:
67Ga-citrate is superior to
111In-oxine-labeled WBC
111In-oxine-labeled WBC is
superior to 111In chloride
111In chloride is superior to
111In-oxine-labeled WBC
111In chloride is superior to
67Ga-citrate
